C. Polwart Et Al. , "British Oncology Pharmacy Association Delphi consensus guidelines: Co-infusion of trometamol-containing calcium folinate (Leucovorin) with systemic anti-cancer treatments," Journal of Oncology Pharmacy Practice , 2024
Polwart, C. Et Al. 2024. British Oncology Pharmacy Association Delphi consensus guidelines: Co-infusion of trometamol-containing calcium folinate (Leucovorin) with systemic anti-cancer treatments. Journal of Oncology Pharmacy Practice .
Polwart, C., Root, T., TEZCAN, S., Meehan, S., Wetherill, B., Waterson, C., ... Burnett, B.(2024). British Oncology Pharmacy Association Delphi consensus guidelines: Co-infusion of trometamol-containing calcium folinate (Leucovorin) with systemic anti-cancer treatments. Journal of Oncology Pharmacy Practice .
Polwart, Calum Et Al. "British Oncology Pharmacy Association Delphi consensus guidelines: Co-infusion of trometamol-containing calcium folinate (Leucovorin) with systemic anti-cancer treatments," Journal of Oncology Pharmacy Practice , 2024
Polwart, Calum Et Al. "British Oncology Pharmacy Association Delphi consensus guidelines: Co-infusion of trometamol-containing calcium folinate (Leucovorin) with systemic anti-cancer treatments." Journal of Oncology Pharmacy Practice , 2024
Polwart, C. Et Al. (2024) . "British Oncology Pharmacy Association Delphi consensus guidelines: Co-infusion of trometamol-containing calcium folinate (Leucovorin) with systemic anti-cancer treatments." Journal of Oncology Pharmacy Practice .
@article{article, author={Calum Polwart Et Al. }, title={British Oncology Pharmacy Association Delphi consensus guidelines: Co-infusion of trometamol-containing calcium folinate (Leucovorin) with systemic anti-cancer treatments}, journal={Journal of Oncology Pharmacy Practice}, year=2024}